Sele-targeted siRNA liposome nanoparticles inhibit pathological scars formation via blocking the cross-talk between monocyte and endothelial cells: a preclinical study based on a novel mice scar model
Luyu Li, Yong Wang, Jing Meng, Xue Wang, Xiaojin Wu, Yan Wo, Ying Shang, Zhen Zhang · 2024
Read Sele-targeted siRNA liposome nanoparticles inhibit pathological scars formation via blocking the cross-talk between monocyte and endothelial cells: a preclinical study based on a novel mice scar model by Luyu Li, Yong Wang, Jing Meng, Xue Wang, Xiaojin Wu, Yan Wo, Ying Shang, Zhen Zhang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11600582.txt.
Description
Luyu Li and co-authors report a scar research study, published in 2024, built around a new mouse model of pathological scarring. Thick scars after trauma and burns impair movement and appearance, and tension on the wound is a key driver. Without a faithful animal model the mechanism stayed murky, so the team built one that stretches healing wounds in a controlled way, bending the back to apply force.
Gene reads from the model scars flagged a vessel protein called E-selectin, also raised in human keloid samples. Stretching raised that protein in vessel cells, drawing in immune cells that fed inflammation. Tiny fat particles carrying gene silencing cargo against the protein, placed under the skin, reduced scar formation, pointing to a treatment route.
Catalog record
| CREATOR | Luyu Li, Yong Wang, Jing Meng, Xue Wang, Xiaojin Wu, Yan Wo, Ying Shang, Zhen Zhang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |